San Jose, CA (PRWEB) July 01, 2013
Follow us on LinkedIn – Breast cancer is one of the most common forms of cancer and is a leading cause of mortality in women worldwide. Studies have proved that early detection of breast cancer increases survival rates in patients. Several governments worldwide have therefore initiated cancer screening programs to curtail the rising incidence of the disease. Breast cancer can be screened through various techniques and tools, including mammography, MRI and clinical examination among others. Each of these techniques has its own unique advantages and varies significantly with respect to sensitivity and specificity from others. However, mammography remains the gold standard technique in breast cancer screening worldwide, driven by a combination of factors such as cost, time taken for the procedure, required expertise to carry out the procedure and the test’s sensitivity and specificity rates.
The global mammography equipment market is witnessing a transition towards digital mammography from the conventional screen-film mammography technology. The trend is promoting demand for full-field digital mammography (FFDM), although digital radiography (DR) and computer radiography (CR) continue to be popular digital technologies in some markets. Continuing technological advances and favorable reimbursement programs in certain countries are expected drive demand for FFDM systems worldwide. With the introduction of new 3D mammography compatible devices, several facilities are replacing their existing devices with new 3D upgradable FFDM devices that will allow them to eventually convert to 3D. CR remains popular in markets such as South America, where the market for DR is yet to make a mark due to higher prices of these devices. On the other hand, countries such as India are witnessing increasing prominence of DR.
Continuous improvements in performance are playing instrumental roles in enhancing the adoption and utility of digital mammography equipment. Advancements in the area of digital technologies have allowed users to minimize radiation dosage without affecting image quality. Other advancements include hybrid imaging with CT and Mammography, which helps in creating improved structural and anatomical images for superior image analysis. However, the development of 3D mammography or breast tomosynthesis remains the biggest innovation in the area of mammography over the recent years. The technology allows creating images at different planes and angles providing better images of the breast tissue.
The first 3D mammography system was launched in Europe in 2008, while the technology made an entry into the US in 2011. 3D mammography is yet to witness rapid growth in adoption and is constrained by the lack of reimbursement in majors markets such as the US and support from large-scale studies. However, with reimbursement for 3D mammography procedures in the US expected to be established in the near-term and positive results from preliminary data from OSLO studies, demand for 3D mammography systems is expected to surge in the coming years. In the US, the 3D mammography technology has initiated a new replacement cycle in the mammography equipment market.
As stated by the new market research report on Mammography Equipment, Europe represents the largest market worldwide. Sluggish implementation of screening programs, economic factors and budgetary constraints have held back growth in the digital mammography market in the region. Asia-Pacific is forecast to emerge as the fastest-growing market with dollar sales projected to grow at a CAGR of 10% over the analysis period. Digital mammography is a relatively new technology in Asia. Efforts from non-government organizations and governments in various Asian countries to promote breast health screening and cancer awareness programs are creating considerable demand for quicker and better mammography services. The trend is expected to create significant demand for mammography equipment in the future.
Major players covered in the report include GE Healthcare, Hologic Inc., I.M.S. (Internazional Medico Scientifica) srl, Philips Healthcare, Planmed Oy, Siemens Healthcare and Toshiba Medical Systems Corp. among others.
The research report titled "Mammography Equipment: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections (US$ and Units) for product segments – Analog Mammography Equipment and Digital Mammography Equipment. Geographic markets analyzed include the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific and Rest of World. The report also provides global installed based data (in units) for analog and digital mammography equipment.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/